Trials / Completed
CompletedNCT00940108
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
A Phase II, Multicentre, Randomised, Observer-blind Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children Aged >= 6 Months to < 9 Years.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 370 (actual)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 6 Months – 8 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether CSL425 is a safe and effective vaccine for eliciting an immune response to H1N1 influenza in healthy children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CSL425 | CSL's 2009 H1N1 Influenza Vaccine, thimerosal-free |
| BIOLOGICAL | CSL425 | CSL's 2009 H1N1 Influenza Vaccine, thimerosal-free |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-10-01
- Completion
- 2010-04-01
- First posted
- 2009-07-15
- Last updated
- 2018-06-28
- Results posted
- 2013-11-20
Locations
5 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00940108. Inclusion in this directory is not an endorsement.